In contrast, mutations in PPM1D and SRCAP, which were present at approximately the same frequency as TP53 mutations in therapy-related clonal hematopoiesis, were uncommon in t-AML/t-MDS. This evidence concerns the gene PPM1D and myelodysplastic syndrome.